Pharmacy benefit manager Prime Therapeutics LLC Eagan Minn. suggested Tuesday it may limit access to PCSK9 inhibitors to patients with familial hypercholesterolemia based on an analysis of its claims data that showed there may be opportunities to first opt...
↧